DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
R••••• O•••••••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $7.5M
sum of BDC pieces, a lower bound
Fair value
$7.5M
101c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Feb 28, 2031
no dated debt inside 24 months
On the tape since
Mar 31, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $7.0M | 100c | SOFR+500 bp | Feb 28, 2031 | 2 |
| first lien revolver first lien | at least $503,000 | 104c | SOFR+500 bp | Feb 28, 2031 | 2 |
| first lien delayed draw term loan first lien | unknown | n/a | S+500 bp | Feb 28, 2031 | 2 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••• C•••••• P•••••• C••••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• M••••••• D••• 2/28/2031 | n/a | n/a n/a | S+500 bp |
| B••• C•••••• P•••••• C••••• | revolver first lien F•••• L••• S••••• S•••••• L••• - R••••••• S••• F•••• 1.00% S••••• 5.00% I••••••• R••• 8.63 | $293,000 | $293,000 104c | SOFR+500 bp |
| B••• C•••••• P•••••• C••••• | term loan first lien F•••• L••• S••••• S•••••• L••• S••• F•••• 1.00% S••••• 5.00% I••••••• R••• 8.64% M••••••• | $6.7M | $6.7M 100c | SOFR+500 bp |
| B••• C•••••• S•••••••• F••••••• I••• | revolver first lien F•••• L••• S••••• S•••••• L••• - R••••••• S••• F•••• 1.00% S••••• 5.00% I••••••• R••• 8.63 | $210,000 | $210,000 104c | SOFR+500 bp |
| B••• C•••••• S•••••••• F••••••• I••• | delayed draw term loan first lien F•••• L••• S••••• S•••••• L••• - D•••••• D••• M••••••• D••• 2/28/2031 | n/a | n/a n/a | S+500 bp |
| B••• C•••••• S•••••••• F••••••• I••• | term loan first lien F•••• L••• S••••• S•••••• L••• S••• F•••• 1.00% S••••• 5.00% I••••••• R••• 8.64% M••••••• | $358,000 | $358,000 101c | SOFR+500 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $7.5M | $7.5M | 101c | 0 |
| Mar 31, 2026 | 2 | $14.3M | $14.3M | 101c | 0 |
| Dec 31, 2025 | 2 | $16.3M | $16.3M | 101c | 0 |
| Sep 30, 2025 | 2 | $18.1M | $18.1M | 101c | 0 |
| Jun 30, 2025 | 2 | $18.1M | $18.0M | 100c | 0 |
| Mar 31, 2025 | 2 | $48.3M | $48.0M | 100c | 0 |
What changed
- New borrower on a BDC scheduleMar 31, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- R••••• O•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it